- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 4, 2026 | 41.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 41.37M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 42.01M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $50M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $25M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $11.98M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $11.74M |
| Capex | Q1 2026 · Mar 31, 2026 | $17.63M |
| Capex | Q1 2026 · Mar 31, 2025 | $50.17M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $35.55M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $7.56M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $15M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $15M |
| Short Term Debt | Q1 2026 · Mar 31, 2025 | $22.5M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $341.01M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $384.14M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $150.29M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.06B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.03B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.86B |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $1.81B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $398.53M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $381.8M |
| Current Liabilities | Q1 2026 · Mar 31, 2025 | $380.03M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $978.37M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $1.04B |
| Total Liabilities | Q1 2026 · Mar 31, 2025 | $952.44M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.36B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.35B |
| Current Assets | Q1 2026 · Mar 31, 2025 | $1.2B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $3.04B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $3.07B |
| Total Assets | Q1 2026 · Mar 31, 2025 | $2.82B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $2.13 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $1.85 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $2.14 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $1.86 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $77.56M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $74.19M |
| Net Income | Q1 2026 · Mar 31, 2026 | $88.22M |
| Net Income | Q1 2026 · Mar 31, 2025 | $77.88M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $114.62M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $102.32M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $265.89M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $250.57M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $322.07M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $288.33M |
| Revenue | Q1 2026 · Mar 31, 2026 | $587.96M |
| Revenue | Q1 2026 · Mar 31, 2025 | $538.9M |
| Stock Issued | Q1 2026 · Mar 31, 2025 | 21K sh |